Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals-Reference-Cited by-同舟云学术

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

Published:2021-03 Issue:10279 Volume:397 Page:1057-1058
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Manisty Charlotte,Otter Ashley D,Treibel Thomas A,McKnight Áine,Altmann Daniel M,Brooks Timothy,Noursadeghi Mahdad,Boyton Rosemary J,Semper Amanda,Moon James C

Funder

Barts Charity

Wellcome Trust

Publisher

Elsevier BV

Subject

General Medicine

Reference4 articles.

1. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine;Polack;N Eng J Med,2020

2. Safety and immunogenicity of two RNA-based COVID-19 vaccine candidates;Walsh;N Engl J Med,2020

3. COVID-19: PCR screening of asymptomatic health-care workers at London hospital;Treibel;Lancet,2020

4. Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection;Reynolds;Sci Immunol,2020

Cited by 377 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody response and its persistence to an inactivated SARS-CoV-2 virus vaccine in young Bangladeshi adults: a prospective study;IMC Journal of Medical Science;2024-09-02

2. Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the “ilmiovaccinoCOVID19 collaborating group”;Frontiers in Drug Safety and Regulation;2024-08-12

3. Hybrid immunity after BNT162b2 Covid-19 vaccine administration in children aged 5 to 11 years;Vaccine;2024-08

4. Safety and antibody response of the BNT162b2 SARS-CoV-2 vaccine in children aged 5–11 years with underlying diseases: A prospective observational study;Journal of Infection and Chemotherapy;2024-08

5. Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination;Cell Reports Medicine;2024-08